P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,451.50
109.85 (2.06%)
BSENSE

May 21

BSE+NSE Vol: 20.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
393.07
644.45
163.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
393.07
644.45
163.95%
Raw Material Cost
222.14
137.79
84.35
61.22%
Purchase of Finished goods
48.27
15.62
32.65
209.03%
(Increase) / Decrease In Stocks
1.80
-7.92
9.72
122.73%
Employee Cost
171.70
86.91
84.79
97.56%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
73.54
199.00
270.60%
Total Expenditure (Excl Depreciation)
716.45
305.93
410.52
134.19%
Operating Profit (PBDIT) excl Other Income
321.07
87.14
233.93
268.45%
Other Income
13.34
46.02
-32.68
-71.01%
Operating Profit (PBDIT)
334.41
133.16
201.25
151.13%
Interest
0.34
7.42
-7.08
-95.42%
Exceptional Items
0.00
-8.95
8.95
100.00%
Gross Profit (PBDT)
334.07
116.79
217.28
186.04%
Depreciation
17.42
39.30
-21.88
-55.67%
Profit Before Tax
316.65
77.50
239.15
308.58%
Tax
84.34
10.03
74.31
740.88%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
67.46
164.85
244.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
67.46
164.85
244.37%
Equity Capital
16.60
19.56
-2.96
-15.13%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
22.17%
0.00
8.78%
Gross Profit Margin
32.20%
29.71%
0.00
2.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024